Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT03057730

A Clinical Trial Testing Root Coverage With Acellular Dermal Matrix in Thin and Thick Gingival Biotypes

Gingival recession is a common defect among the American population. It is also a major cause for root decay, hypersensitivity, contributes to tooth mobility and low self-esteem. Acellular dermal matrix, a human-derived grafting material has been put on the market for the treatment of gingival recession. Treating gingival recession with this material has been a validated treatment option for years.

However, treatment outcomes in two patient populations, namely those with thin biotypes and those with thick biotypes, has not been investigated. This study will observe the primary treatment outcomes in the two patient groups at 5 time points - 3 months, 6 months and 12 months post-surgery to observe short term outcomes; additional 24 months and 48 months post-surgery to observe long term outcomes.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Conditions

Gingival Recession Gingival Diseases Mouth Diseases Periodontal Atrophy Periodontal Diseases Stomatognathic Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Tufts University School of Dental Medicine

Boston, Massachusetts, 02111, United States

About this study

The study aim is to evaluate and compare the use of acellular dermal matrix, a material used for treating gum recession, in two study populations, namely thin or thick gingival biotype. Short term outcomes and the long term stability of ADM in recession repair between thick and thin biotypes will be evaluated.

There will be two study groups, namely thin and thick groups. The included subjects will be divided in two groups according to gingival thickness: Thin gingival biotype group (TnB): < 0.8 mm, thick gingival biotype group (TkB) ≥ 0.8 mm. Each subject will be in one of the two groups only.

Randomization will not be used to assign the subjects to the study groups, because the intervention will be the same for both groups, namely ADM applied beneath a coronally advanced flap.

The short term (3 months, 6 months post-surgery) outcomes and the longer term (12 months, 24 months and 48 months post-surgery) outcomes will further be compared within the groups and between the groups.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subjects must be current patients of Tufts University School of Dental Medicine
  • Subjects with two Miller class I or class II adjacent recessions with a recession height ≥ 2 mm and < 4 mm
  • Affected tooth/teeth are anterior- incisors, canines or premolars (except the mandibular central and lateral incisors)
  • Healthy subjects with no contraindications to root coverage surgery
  • Subjects with full-mouth plaque index<1 and gingival index<1, calculated as the average value of plaque index and gingival index

Exclusion criteria

  • Presence of adjacent defects, whose gingival thickness values place them in a different category other than thick or thin biotype
  • Areas that have previously been treated with root coverage surgeries
  • Subjects with a known hypersensitivity to polysorbate 20 (contraindicated with the use of Alloderm®)
  • Subject smokes more than 5 cigarettes per day
  • Subjects with systemic conditions which influence wound healing
  • Subjects that are pregnant or lactating
  • Subjects with a condition causing immunosuppression, or currently taking immunosuppressant medications
  • Teeth with severe occlusal interferences, deep cervical lesions, or large restorations whose margins impinge on the cement-enamel junction or make identification of this landmark impossible

Treatment and study plan

Acellular Dermal Matrix

Biological

ADM is a human-derived allograft material, treated to remove all cellular components so that only the connective tissue matrix remains.

Other names: Alloderm®

Primary outcomes

  1. Change in Mean Root Coverage

    Time frame: Up to 48 months post surgery

    Root coverage will be measured in mm using a probe and digital caliper. Mean root coverage will be measured per patient by averaging the two study teeth. Change in mean root coverage for the primary outcome will be assessed by the difference between the baseline mean root coverage and the final mean root coverage at 48 months post surgery.

Secondary outcomes

  1. Change in Clinical Probing Depth (CPD)

    Time frame: Up to 48 months post surgery

  2. Change in Clinical Attachment Level (CAL)

    Time frame: Up to 48 months post surgery

    CAL will be measured from the base of the pocket to the cementoenamel junction (CEJ) in mm using a probe and digital caliper. Change in CAL will be assessed from baseline to 48 months post surgery.

  3. Change in Recession Height (RH)

    Time frame: Up to 48 months post surgery

  4. Change in Recession Width (RW)

    Time frame: Up to 48 months post surgery

  5. Change in Keratinized Tissue Width

    Time frame: Up to 48 months post surgery

  6. Change in Gingival Thickness (GT)

    Time frame: Up to 48 months post surgery

  7. Complete Root Coverage (CRC)

    Time frame: Up to 48 months post surgery

    CRC will be assessed using descriptive statistics (# subjects with CRC out of the total sample)

Sponsors and collaborators

Lead sponsor

Tufts University

Other

Registry information

Official study title

Acellular Dermal Matrix Combined With Coronally Advanced Flap in the Treatment of Multiple Recession Defects in Thin Versus Thick Periodontal Biotype Population: A Controlled Clinical Investigation

Important dates

Study start
2015
Primary completion
2025
Study completion
2025
First posted
Feb 20, 2017
Registry last updated
Aug 20, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.